Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Drug Metab Dispos
2012 Jun 01;406:1138-43. doi: 10.1124/dmd.111.042432.
Show Gene links
Show Anatomy links
Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.
Itagaki S, Ganapathy V, Ho HT, Zhou M, Babu E, Wang J.
???displayArticle.abstract??? Plasma membrane monoamine transporter (PMAT) is a polyspecific organic cation (OC) transporter that transports a variety of endogenous biogenic amines and xenobiotic cations. Previous radiotracer uptake studies showed that PMAT-mediated OC transport is sensitive to changes in membrane potential and extracellular pH, but the precise role of membrane potential and protons on PMAT-mediated OC transport is unknown. Here, we characterized the electrophysiological properties of PMAT in Xenopus laevis oocytes using a two-microelectrode voltage-clamp approach. PMAT-mediated histamine uptake is associated with inward currents under voltage-clamp conditions, and the currents increased in magnitude as the holding membrane potential became more negative. A similar effect was also observed for another cation, nicotine. Substrate-induced currents were largely independent of Na+ but showed strong dependence on membrane potential and pH of the perfusate. Detailed kinetic analysis of histamine uptake revealed that the energizing effect of membrane potentials on PMAT transport is mainly due to an augmentation of Imax with little effect on K0.5. At most holding membrane potentials, Imax at pH 6.0 is approximately 3- to 4-fold higher than that at pH 7.5, whereas K0.5 is not dependent on pH. Together, these data unequivocally demonstrate PMAT as an electrogenic transporter and establish the physiological inside-negative membrane potential as a driving force for PMAT-mediated OC transport. The important role of membrane potential and pH in modulating the transport activity of PMAT toward OCs suggests that the in vivo activity of PMAT could be regulated by pathophysiological processes that alter physiological pH or membrane potential.
Budiman,
Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat.
2000, Pubmed
Budiman,
Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat.
2000,
Pubmed Busch,
Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1.
1996,
Pubmed
,
Xenbase Dahlin,
Expression profiling of the solute carrier gene family in the mouse brain.
2009,
Pubmed Dahlin,
Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.
2007,
Pubmed Dascal,
Voltage clamp recordings from Xenopus oocytes.
2001,
Pubmed
,
Xenbase Dascal,
Xenopus oocyte resting potential, muscarinic responses and the role of calcium and guanosine 3',5'-cyclic monophosphate.
1984,
Pubmed
,
Xenbase Dresser,
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
2000,
Pubmed
,
Xenbase Duan,
Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
2010,
Pubmed Engel,
Identification and characterization of a novel monoamine transporter in the human brain.
2004,
Pubmed
,
Xenbase Engel,
Interaction of organic cations with a newly identified plasma membrane monoamine transporter.
2005,
Pubmed Fei,
The amino acid transport system y+L induced in Xenopus laevis oocytes by human choriocarcinoma cell (JAR) mRNA is functionally related to the heavy chain of the 4F2 cell surface antigen.
1995,
Pubmed
,
Xenbase Fujita,
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.
2006,
Pubmed Gorboulev,
Cloning and characterization of two human polyspecific organic cation transporters.
1997,
Pubmed
,
Xenbase Gründemann,
Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells.
1997,
Pubmed Ho,
Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.
2011,
Pubmed Kekuda,
Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.
1998,
Pubmed
,
Xenbase Koepsell,
Organic cation transporters.
2003,
Pubmed Koepsell,
The SLC22 drug transporter family.
2004,
Pubmed Kong,
Mammalian nucleoside transporters.
2004,
Pubmed Loo,
Relaxation kinetics of the Na+/glucose cotransporter.
1993,
Pubmed
,
Xenbase Masuda,
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.
2006,
Pubmed Okuda,
cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.
1996,
Pubmed
,
Xenbase Okura,
Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers.
2011,
Pubmed Otsuka,
A human transporter protein that mediates the final excretion step for toxic organic cations.
2005,
Pubmed Sweet,
rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.
1999,
Pubmed
,
Xenbase Terada,
Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
2006,
Pubmed Urakami,
Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
1998,
Pubmed Wright,
Molecular and cellular physiology of renal organic cation and anion transport.
2004,
Pubmed Wu,
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain.
1998,
Pubmed
,
Xenbase Xia,
Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells.
2007,
Pubmed Xia,
Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.
2009,
Pubmed Zhou,
Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain.
2007,
Pubmed
,
Xenbase Zhou,
Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
2007,
Pubmed
